
Glaukos appoints Chris Money
Well-known to the New Zealand ophthalmic technology market, Chris Money has recently joined Glaukos as senior regional business manager.

Well-known to the New Zealand ophthalmic technology market, Chris Money has recently joined Glaukos as senior regional business manager.

A 600-metre long net that endangered marine life in the Great Barrier Reef has been bought by World Wildlife Fund for Nature-Australia to be turned into sustainable sunglasses.

BHVI has announced it is 'embarking on a new strategic roadmap', with an organisational restructure and a new managing director of its science arm VisionCRC on board.Dr Arthur Back, formerly of

First steps are being made by the Ministry of Health towards establishing its new Health Infrastructure Unit to support and oversee the building of new clinical facilities in New Zealand, with two new

A clinical trial comparing methotrexate and the more expensive mycophenolate mofetil treating non-infectious uveitis shows the two drugs offer very similar results.

Researchers from École Polytechnique Fédérale de Lausanne in Switzerland and Scuola Superiore Sant’Anna in Italy have developed a new type of intraneural electrode that bypasses the eyeball entirely

A retrospective review found low-level light therapy (LLLT) successfully resolved recalcitrant chalazia in most patients who failed topical or systemic therapy, significantly reducing the need for

Researchers at SUNY Downstate Health Sciences University in Brooklyn are working on a science fiction-esque optogenetic technology to give blind people the ability to see. The OBServ visual

Safilo, Marchon and Luxottica were all winners at the US Accessories Council’s first annual Design Excellence Awards, hosted at the New York Plaza Hotel in September. Honouring outstanding

A new organisation to promote the development and knowledge of scleral lenses, the Euro and Austral-Asian Scleral Lens Academy (EASLA), has been created to cater to the public and professionals in

Digital security is under the microscope, with the Ministry of Health encouraging health organisations to ensure the digital services they use are safe and reliable by the publication

Iconic Kiwi author Dame Joy Cowley, best known for her children's fiction, such as the popular Mrs Wishy-Washy series, suffers from macular degeneration (MD).Featherstone-based Cowley, aged 82, wrote